Patents by Inventor Philip Andrew Hay

Philip Andrew Hay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1-acetic acid-indole derivatives with PGD2 antagonist activity
    Patent number: 8044088
    Abstract: Compounds of general formula (I) wherein R1 is halo or cyano; R2 is C1-C4 alkyl; and R3 is phenyl substituted with one or more substituents chosen from C1-C6 alkyl, halo or —SO2(C1-C6 alkyl); or a pharmaceutically acceptable salt, hydrate, solvate, complex or prodrug thereof; are useful in the treatment of diseases and conditions mediated by the action of PGD2 at the CRTH2 receptor.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: October 25, 2011
    Assignee: Oxagen Limited
    Inventors: Richard Edward Armer, Edward Andrew Boyd, Judith Helen Boyd, legal representative, Philip Andrew Hay
  • 1-ACETIC ACID-INDOLE DERIVATIVES WITH PGD2 ANTAGONIST ACTIVITY
    Publication number: 20100330077
    Abstract: Compounds of general formula (I) wherein R1 is halo or cyano; R2 is C1-C4 alkyl; and R3 is phenyl substituted with one or more substituents chosen from C1-C6 alkyl, halo or —SO2(C1-C6 alkyl); or a pharmaceutically acceptable salt, hydrate, solvate, complex or prodrug thereof; are useful in the treatment of diseases and conditions mediated by the action of PGD2 at the CRTH2 receptor.
    Type: Application
    Filed: March 10, 2006
    Publication date: December 30, 2010
    Applicant: OXAGEN LIMITED
    Inventors: Richard Edward Armer, Edward Andrew Boyd, Philip Andrew Hay
  • Furanthiazole derivatives as heparanase inhibitors
    Patent number: 7326727
    Abstract: The invention provides a compound of formula (I) or a pharmaceutically acceptable salt or prodrug thereof: (I) wherein the groups Q, R2, R3, R4 and R5 represent various substituent groups, and their use as inhibitors of heparanase.
    Type: Grant
    Filed: August 5, 2003
    Date of Patent: February 5, 2008
    Assignee: Oxford Glycosciences (UK) Ltd.
    Inventors: Stephen Martin Courtney, Philip Andrew Hay, David Ian Carter Scopes
  • Phthalimide carboxylic acid derivatives
    Patent number: 7138425
    Abstract: The present invention relates to phthalimide carboxylic acid derivatives of formula (I), methods for their preparation, pharmaceutical compositions containing them and their use in medicine, specifically in the treatment of cancer. (I), wherein X is O or S; R1 is a phthalimide carboxylic acid group of formula (II).
    Type: Grant
    Filed: March 6, 2003
    Date of Patent: November 21, 2006
    Assignee: Oxford Glycoscience (UK) Ltd.
    Inventors: Stephen Martin Courtney, Philip Andrew Hay, David Ian Carter Scopes